Fig. 4From: Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibodyMean concentrations of Aβ(1-40) versus nominal time for SAD cohorts. Aβ amyloid β, SAD single ascending doseBack to article page